Truist Securities Downgrades Doximity to Hold, Lowers Price Target to $29

Benzinga Newsdesk www.benzinga.com Negative 87.6%

Neg 87.6% Neu 0% Pos 0%

Truist Securities analyst Jailendra Singh downgrades Doximity (NYSE:DOCS) from Buy to Hold and lowers the price target from $37 to $29.